Hilde Furberg has over 30 years of commercial experience in Pharma and Biotech, she is currently Senior Vice President Rare Diseases EMEA at Genzyme a Sanofi Company. Previously her roles were Vice President and General Manager of Nordic Benelux and Nordic General Manager at Genzyme. Prior to joining Genzyme, Ms. Furberg was Managing Director and part-owner of Pharmalink and held a number of roles at Baxter including Managing Director Sweden. She is currently a board member at Pharmalink and has held board positions at Algeta, Clavis, Pronova and Probi.
Pharma and Biotech